The functional pathway analysis demonstrated that PKC-δ inhibition affected the transcriptional levels of genes from diverse pathways that are involved in a variety of pathological conditions, such as: cancer, inflammatory, gastrointestinal, reproductive, cardiovascular and hematological diseases. This evidence concerns the gene PRKCD and cancer.